{"id":5665,"date":"2009-04-04T15:12:58","date_gmt":"2009-04-04T15:12:58","guid":{"rendered":"https:\/\/medicalcriteria.com\/web\/nephcin\/"},"modified":"2025-05-14T19:09:28","modified_gmt":"2025-05-14T19:09:28","slug":"nephcin","status":"publish","type":"post","link":"https:\/\/medicalcriteria.com\/web\/es\/nephcin\/","title":{"rendered":"Factores de Riesgo para Nefropat\u00eda Inducida por Contraste (NIC)"},"content":{"rendered":"<div class=\"7ca9444b8380138fe077da07353677a4\" data-index=\"1\" style=\"float: none; margin:0px 0 0px 0; text-align:center;\">\n<script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js\"><\/script>\r\n<!-- MC 2019- Horizontal -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-0127150553352455\"\r\n     data-ad-slot=\"3806776041\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script>\n<\/div>\n<p>La nefropat\u00eda inducida por contraste (NIC) se define como la alteraci\u00f3n de la funci\u00f3n renal y se mide como un incremento del 25% en la creatinina s\u00e9rica (Cr) desde el valor inicial o de 0,5 mg\/dL (44 umol\/L) en valor absoluto, en 48 -72 horas de administraci\u00f3n de contraste intravenoso.<!--more--><\/p>\n<p><strong>Factores de Riesgo para Nefropat\u00eda Inducida por Contraste (NIC)<\/strong><\/p>\n<p>1. Insuficiencia renal preexistente<br \/>\n2. Diabetes mellitus con insuficiencia renal.<br \/>\n3. Volumen intravascular reducido<\/p>\n<ul>\n<li>Insuficiencia card\u00edaca congestiva<\/li>\n<li>Diur\u00e9ticos (especialmente furosemida)<\/li>\n<li>P\u00e9rdidas anormales de fluidos<\/li>\n<li>Insuficiencia hep\u00e1tica<\/li>\n<li>S\u00edndrome nefr\u00f3tico<\/li>\n<li>Deshidrataci\u00f3n<\/li>\n<\/ul>\n<p>4. Hipotensi\u00f3n prolongada<\/p>\n<ul>\n<li>Uso concomitante de diur\u00e9ticos e inhibidores de la enzima convertidora de angiotensina (ECA)<\/li>\n<li>Complicaci\u00f3n de la angiograf\u00eda coronaria.<\/li>\n<\/ul>\n<p>5. Medios de contraste<\/p>\n<ul>\n<li>Grandes vol\u00famenes (&gt; 140 ml)<\/li>\n<li>Inyecciones repetidas dentro de las 72 horas.<\/li>\n<li>Alta osmolaridad<\/li>\n<\/ul>\n<p>6. Diabetes mellitus<br \/>\n7. Drogas nefrot\u00f3xicas<\/p>\n<ul>\n<li>p.ej. F\u00e1rmacos anti-inflamatorios no esteroideos<\/li>\n<li>Aminogluc\u00f3sidos<\/li>\n<\/ul>\n<p>8. Edad avanzada<br \/>\n9. Hipertensi\u00f3n<br \/>\n10. Proteinuria (incluido el s\u00edndrome nefr\u00f3tico)<br \/>\n11. Mieloma m\u00faltiple<br \/>\n12. Hipercolesterolemia<br \/>\n13. Hiperuricemia<br \/>\n14. Hipercalcemia<br \/>\n15. Sepsis<br \/>\n16. Alergia at\u00f3pica<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Bibliograf\u00eda:<\/strong><\/p>\n<ol>\n<li>Gleeson TG, Bulugahapitiya S. Contrast-induced nephropathy. AJR Am J Roentgenol. 2004 Dec;183(6):1673-89. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/15547209\/\" target=\"_blank\" rel=\"noopener\">[Medline]<\/a><\/li>\n<li>Gleeson TG, O\u2019Dwyer J, Bulugahapitiya S, Foley DP. Contrast-induced nephropathy. Br J Cardiol 2004;11:AIC53-AIC61.<\/li>\n<\/ol>\n<p>&nbsp;<\/p>\n<p>Creado: Abr 4, 2009<\/p>\n<p>&nbsp;<\/p>\n\n<div style=\"font-size: 0px; height: 0px; line-height: 0px; margin: 0; padding: 0; clear: both;\"><\/div>","protected":false},"excerpt":{"rendered":"<p>La nefropat\u00eda inducida por contraste (NIC) se define como la alteraci\u00f3n de la funci\u00f3n renal y se mide como un incremento del 25% en la creatinina s\u00e9rica (Cr) desde el valor inicial o de 0,5 mg\/dL (44 umol\/L) en valor absoluto, en 48 -72 horas de administraci\u00f3n de contraste intravenoso.<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_lmt_disableupdate":"no","_lmt_disable":"no","_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":""},"categories":[473],"tags":[2038,2037,2036,1893,1894,960,959,2035,1353,2034,836,767],"class_list":["post-5665","post","type-post","status-publish","format-standard","hentry","category-nephrology","tag-cin","tag-contrast","tag-contraste","tag-factores","tag-factors","tag-induced","tag-inducida","tag-nefropatia","tag-nephrology","tag-nephropathy","tag-riesgo","tag-risk"],"modified_by":"Guillermo Firman","_links":{"self":[{"href":"https:\/\/medicalcriteria.com\/web\/es\/wp-json\/wp\/v2\/posts\/5665","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicalcriteria.com\/web\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicalcriteria.com\/web\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicalcriteria.com\/web\/es\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/medicalcriteria.com\/web\/es\/wp-json\/wp\/v2\/comments?post=5665"}],"version-history":[{"count":3,"href":"https:\/\/medicalcriteria.com\/web\/es\/wp-json\/wp\/v2\/posts\/5665\/revisions"}],"predecessor-version":[{"id":9152,"href":"https:\/\/medicalcriteria.com\/web\/es\/wp-json\/wp\/v2\/posts\/5665\/revisions\/9152"}],"wp:attachment":[{"href":"https:\/\/medicalcriteria.com\/web\/es\/wp-json\/wp\/v2\/media?parent=5665"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicalcriteria.com\/web\/es\/wp-json\/wp\/v2\/categories?post=5665"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicalcriteria.com\/web\/es\/wp-json\/wp\/v2\/tags?post=5665"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}